Blog
What is the optimal approach for using digital cognitive biomarkers in clinical trials?
Digital cognitive biomarkers are typically active or passive: but which approach enhances clinical trial success? Here we will define how active and passive cognitive biomarkers function in clinical trials, to conclude their optimal application.
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
stress,
social cognition,
smartphones,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
recruitment,
psychosis,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
ots,
occupational health,
nutrition,
neuroscience,
near-patient testing,
multiple sclerosis,
mts,
ms,
mental wellbeing,
mental health,
mdd,
mci,
major depression,
machine learning,
life at cambridge cognition,
jobs at cambridge cognition,
international women's day,
ied,
hot cognition,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
cambridge cognition,
brain health,
bipolar disorder,
biomarkers,
automatic speech recognition,
attention,
alzheimer's disease,
affective cognition,
academic,
absenteeism,
aaic2020,
aaic,
